AZ Sint-Lucas Gent
AZ Sint-Lucas Gent
Ghent, Belgium1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2024-07-26 | NCT06113913 |